PACS Group, Inc.
PACSNYSEHealthcare · Services-Skilled Nursing Care Facilities · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $3.11B | $2.40B |
| Operating income | $309.6M | $123.1M | $207.8M | $229.4M |
| Net income | $191.5M | $55.8M | $112.9M | $150.5M |
| Total assets | $5.58B | $5.24B | $3.51B | — |
| Total liabilities | $4.63B | $4.53B | $3.41B | — |
| Equity | $946.8M | $709.6M | $96.1M | $68.7M |
| EPS (diluted) | $1.22 | $0.38 | $0.88 | $1.17 |
| Shares out. | 156.6M | 155.2M | 128.7M | 128.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 5.9%
- Net margin
- 3.6%
- Return on equity
- 20.2%
- Return on assets
- 3.4%
- Return on capital (ROCE)
- 6.8%
- Liabilities / assets
- 82.9%
- Debt / equity
- 4.89×
- Book value / share
- $6.05
- Revenue growth (YoY)
- 29.4%
- Net income growth (YoY)
- 243.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.85distress
- Accruals / assets
- −3.8%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Hancock MarkPassive (13G)Feb 13, 2025
- Murray Jason HulsePassive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.3M | 4.2 | -10.2% |
| Apr 30, 2026 | 4.8M | 5.8 | +8.1% |
| Apr 15, 2026 | 4.4M | 6.5 | +3.8% |
| Mar 31, 2026 | 4.3M | 5.2 | +16.0% |
| Mar 13, 2026 | 3.7M | 4.8 | -6.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Director / officer change · Regulation FD disclosureApr 27, 2026
- Director / officer change · Regulation FD disclosureMar 5, 2026
- Results of operationsFeb 26, 2026
- Shareholder voteDec 23, 2025
- Entered a material agreementDec 1, 2025
- Results of operationsNov 19, 2025
- Other material eventNov 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.